Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings
About Cisen Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 辰欣药业股份有限公司董事会关于独立董事独立性自查情况的专项报告 | 2026-04-02 | Chinese | |
| 辰欣药业股份有限公司2025年度董事会审计委员会履职情况报告 | 2026-04-02 | Chinese | |
| 辰欣药业股份有限公司2025年度董事会工作报告 | 2026-04-02 | Chinese | |
| 辰欣药业股份有限公司关于2025年度利润分配方案的公告 | 2026-04-02 | Chinese | |
| 辰欣药业股份有限公司2025年度独立董事述职报告(王唯佳) | 2026-04-02 | Chinese | |
| 辰欣药业股份有限公司关于召开2025年年度股东会通知 | 2026-04-02 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 37406688 | 辰欣药业股份有限公司董事会关于独立董事独立性自查情况的专项报告 | 2026-04-02 | Chinese | ||
| 37406686 | 辰欣药业股份有限公司2025年度董事会审计委员会履职情况报告 | 2026-04-02 | Chinese | ||
| 37406683 | 辰欣药业股份有限公司2025年度董事会工作报告 | 2026-04-02 | Chinese | ||
| 37406679 | 辰欣药业股份有限公司关于2025年度利润分配方案的公告 | 2026-04-02 | Chinese | ||
| 37406672 | 辰欣药业股份有限公司2025年度独立董事述职报告(王唯佳) | 2026-04-02 | Chinese | ||
| 37406670 | 辰欣药业股份有限公司关于召开2025年年度股东会通知 | 2026-04-02 | Chinese | ||
| 37406668 | 辰欣药业股份有限公司第五届董事会第十二次会议决议公告 | 2026-04-02 | Chinese | ||
| 37406666 | 大信会计师事务所(特殊普通合伙)关于辰欣药业股份有限公司内控审计报告 | 2026-04-02 | Chinese | ||
| 37406662 | 辰欣药业股份有限公司关于召开2025年度业绩暨现金分红说明会的公告 | 2026-04-02 | Chinese | ||
| 37406657 | 辰欣药业股份有限公司董事会审计委员会对会计师事务所2025年度履行监督职责情况报告 | 2026-04-02 | Chinese | ||
| 37406653 | 辰欣药业股份有限公司2025年度对会计师事务所履职情况评估报告 | 2026-04-02 | Chinese | ||
| 37406651 | 辰欣药业股份有限公司董事和高级管理人员薪酬管理制度(2026年4月) | 2026-04-02 | Chinese | ||
| 37406647 | 辰欣药业股份有限公司2025年度独立董事述职报告(张自然) | 2026-04-02 | Chinese | ||
| 37406646 | 辰欣药业股份有限公司股东减持股份计划公告 | 2026-03-13 | Chinese | ||
| 37406636 | 辰欣药业股份有限公司关于变更保荐代表人的公告 | 2026-02-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cisen Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57632/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57632 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57632 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57632 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57632}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cisen Pharmaceutical Co.,Ltd. (id: 57632)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.